http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106946935-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_477168f6ef414d265d7cbfae89a6d49b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
filingDate 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d539dc40a5fbea5821d22a24d80a99c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc7e3a9b92ee6e7c600c5ddbb9b533b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_443bdf8c2b6304c1594ed83987611604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5675baa1243b1d8fa232d0d849e086c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4de68f2507e1625268ca1e4f455ca0
publicationDate 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106946935-A
titleOfInvention A kind of preparation method of diastereomer nucleoside derivative
abstract The present invention relates to a preparation method of diastereoisomer compound I, said method comprising the following steps: compound III is heated and stirred in an organic solvent to transform its configuration to obtain compound I, wherein X group The group is a halogen; compared with the prior art, the preparation method of the present invention has cheap and easy-to-get raw materials, mild reaction conditions, few side reactions, high yield, little environmental pollution, and is suitable for industrialized production. It is tenofofumarate The preparation of the key intermediate of Vilafenamide provides a new way.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107522743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110981911-A
priorityDate 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103842366-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015107451-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465904463

Total number of triples: 20.